Envoke

Investor: Foresight Group

Envoke, a UK-based company providing remote training and support for medics using complex laboratory equipment, has secured a £1.6 million investment from existing investors including Foresight Group. Summary of transaction details: Value: £1.6 million Sector: Healthcare & Biotech Advisor: None Key Entities: Envoke, Foresight Group Location: UK, Asia-Pacific Note: The investment in Envoke is a strategic move to expand the company's reach into the Asia-Pacific market, capitalizing on the growing demand for remote training and support solutions in the healthcare sector.

Investor: NPIF – Mercia Equity Finance, Finance Yorkshire, and Foresight Group

Leeds-based health technology company Envoke has raised £1.6 million in a VC funding round led by NPIF – Mercia Equity Finance, Finance Yorkshire's Seedcorn Fund, and Foresight Group. The investment will support the company's international expansion, particularly into the Asia-Pacific market, following its development of a virtual laboratory simulation platform used for remote training and equipment maintenance across the healthcare sector.Summary of transaction details:Value: £1.6 millionSector: Healthcare & Biotech / Health TechnologyAdvisor: N/AKey Entities: Envoke (target); NPIF – Mercia Equity Finance, Finance Yorkshire, and Foresight Group (investors)Location: Leeds, United KingdomNote: This funding round brings Envoke's total capital raised to over £4 million. The investment follows the company's growing traction with major global customers including Bio-Rad, ThermoFisher Scientific, PacBio, and Haemonetics, and is aimed at accelerating international expansion into the Asia-Pacific region, supported by recent contract wins with Hawaii's national blood laboratories and the US-based Mayo Clinic.